Delivery of modified mRNA encoding vesicular stomatitis virus matrix protein for colon cancer gene therapy-Reference-Cited by-同舟云学术

Delivery of modified mRNA encoding vesicular stomatitis virus matrix protein for colon cancer gene therapy

Published:2018 Issue:22 Volume:8 Page:12104-12115
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Men Ke¹²³⁴⁵^ORCID,Zhang Rui¹²³⁴⁵,Zhang Xueyan¹²³⁴⁵,Huang Rong¹²³⁴⁵,Zhu Guonian¹²³⁴⁵,Tong Rongsheng⁶⁷⁸⁹⁵,Yang Li¹²³⁴⁵,Wei Yuquan¹²³⁴⁵,Duan Xingmei¹²³⁴⁵

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy

2. West China Hospital

3. Sichuan University

4. Chengdu 610041

5. People's Republic of China

6. Individualized Medication Key Laboratory of Sichuan Province

7. Department of Pharmacy

8. Sichuan Provincial People's Hospital

9. Chengdu

Abstract

Liposome–protamine complex delivered VSVMP mRNA efficiently inhibits C26 colon carcinoma with safety, providing an alternative strategy for non-viral gene therapy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C7RA13656K

Reference49 articles.

1. Colorectal cancer statistics, 2017

2. Engineering adeno-associated viruses for clinical gene therapy

3. Gene therapy returns to centre stage

4. Non-viral vectors for gene-based therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review;Nano TransMed;2024-12

2. Injectable and Photocurable Gene Scaffold Facilitates Efficient Repair of Spinal Cord Injury;ACS Applied Materials & Interfaces;2024-01-08

3. Systemic and Local Administration of a Dual-siRNA Complex Efficiently Inhibits Tumor Growth and Bone Invasion in Oral Squamous Cell Carcinoma;Molecular Pharmaceutics;2024-01-04

4. Oral non-viral gene delivery platforms for therapeutic applications;International Journal of Pharmaceutics;2023-07

5. Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles;International Journal of Pharmaceutics;2023-04